FDA Watch: New Test for Esophageal Conditions is Coming to the US
UK-developed assay that uses a sponge appears to reduce the need for more invasive endoscopies.
UK-developed assay that uses a sponge appears to reduce the need for more invasive endoscopies.
More aggressive use of artificial intelligence may mitigate issues that lead to the uneven impact of the disease on this group.
Is at-home sample collection the solution to lagging cancer screening uptake—or does this approach introduce a new set of challenges?
G2’s list of major FDA approvals includes cancer and liquid biopsy, COVID-19, STI, and neurologic tests.
First marketing authorization of a blood test assessing genetic variants related to cancer opens the door for clearance of similar tests.